Henry Ji
CIK 1470981 · Exec Chair, CEO and President · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$58.2K
Companies
2
Total Filings
64
Lifetime Open-Market Net
$1.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCLXW | Exec Chair, CEO and President | 322,910 | $0.18 | $58.2K | $62.0K | 9 | 2026-04-20 |
| Sorrento Therapeutics, Inc. (SRNE) Delisted | See Remarks | 6,305,805 | $0.00 | $3.2K | $1.87M | 43 | 2022-12-23 |
Recent Filings · Page 5 of 7
64 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-08-21 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Buy (P) | +8,888 | $116.2K | EDGAR |
| 2015-02-26 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-05 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Gift (G) | −25,000 | -$252.7K | EDGAR |
| 2014-11-10 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Buy (P) | +5,999 | $28.9K | EDGAR |
| 2014-11-07 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Buy (P) | +4,000 | $18.2K | EDGAR |
| 2014-11-06 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Buy (P) | +3,000 | $13.6K | EDGAR |
| 2014-10-09 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-29 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Gift (G) | −20,000 | $0 | EDGAR |
| 2013-12-05 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Buy (P) | +1,000 | $8.9K | EDGAR |
| 2013-12-05 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Buy (P) | +1,000 | $8.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.